Kolexia
Bombois Stephanie
Neurologie
Hôpital Pitie Salpetriere
Paris, France
163 Activités
145 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie d'Alzheimer Démence Accident vasculaire cérébral Démence frontotemporale Hémorragie cérébrale Encéphalopathie ischémique COVID-19 Hémorragie Angiopathie amyloïde cérébrale

Industries

Eisai
3 collaboration(s)
Dernière en 2021
Biogen
2 collaboration(s)
Dernière en 2021
UCB
1 collaboration(s)
Dernière en 2021
Novo Nordisk
1 collaboration(s)
Dernière en 2023

Dernières activités

The free plasma amyloid Aβ /Aβ ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ /Aβ ratio. The BALTAZAR study.
Neurobiology of disease   27 février 2024
PROGRESS-AD: A Phase 2, Parallel Group, Randomized, Double- Blind, Placebo-Controlled, 3-Arm, Multicenter Treatment Study to Evaluate the Efficacy and Safety of GSK4527226 [AL101] Intravenous Infusion Compared With Placebo in Patients With Early Alzheimer's Disease
Essai Clinique (GSK)   12 février 2024
Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening.
Genetics in medicine : official journal of the American College of Medical Genetics   24 janvier 2024
Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer's Disease Continuum.
International journal of molecular sciences   11 décembre 2023
Head-to-Head Comparison of Two Plasma Phospho-tau Assays in Predicting Conversion of Mild Cognitive Impairment to Dementia.
Clinical chemistry   04 septembre 2023
INSIGHT-2: Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study
Essai Clinique (Institut National de la Santé Et de la Recherche Médicale, France)   07 avril 2023
Disentangling Clinical Profiles of Apathy in Behavioral Variant Frontotemporal Dementia.
Journal of Alzheimer's disease : JAD   03 avril 2023
Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function.
Journal of neurology, neurosurgery, and psychiatry   03 avril 2023
Validation study of "Santé-Cerveau", a digital tool for early cognitive changes identification.
Alzheimer's research & therapy   03 avril 2023
Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression.
Neurobiology of disease   30 mars 2023